A new genotoxicity assay based on p53 target gene induction
- PMID: 26232255
- DOI: 10.1016/j.mrgentox.2015.05.010
A new genotoxicity assay based on p53 target gene induction
Abstract
The p53 tumor suppressor protein has emerged as a universal sensor of genotoxic stress that regulates the transcription of numerous genes required for appropriate cellular response to DNA damage. Therefore, transcriptional induction of p53 target genes can be considered as a global and early indicator of genotoxic stress. By performing expression microarrays and RNA-Seq analysis on wild-type and mutant TP53 human lymphocytes respectively derived from controls and Li-Fraumeni patients and exposed to different classes of genotoxic agents, we first determined a common p53-dependent transcriptional signature of DNA damage. We then derived a simple and fast assay based on the exposure of wild-type TP53 lymphocytes to physical or chemical agents and on the quantitative measurement of selected p53 target gene transcriptional induction. The specificity of the p53 genotoxicity assay can easily be demonstrated by performing the same experiment in control lymphocytes with heterozygous TP53 mutations, which compromise responses to DNA damage. This assay allowed us to show that most of the drugs commonly used in cancer treatment, except the microtubule poisons, are highly genotoxic. The p53 genotoxicity assay should facilitate the measurement of the genotoxic effects of chemical and physical agents and the identification of drugs that are not genotoxic and do not expose patients to the risk of secondary malignancies, especially those with a constitutional defect in response to DNA damage, such as patients with Li-Fraumeni syndrome.
Keywords: Cancer; Chemotherapy; DNA damage; Genotoxicity; Li-Fraumeni syndrome; TP53.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.Hum Mol Genet. 2017 Jul 15;26(14):2591-2602. doi: 10.1093/hmg/ddx106. Hum Mol Genet. 2017. PMID: 28369373 Free PMC article.
-
Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients.Hum Mutat. 2013 Mar;34(3):453-61. doi: 10.1002/humu.22254. Epub 2013 Feb 11. Hum Mutat. 2013. PMID: 23172776
-
Contribution of genotoxic anticancer treatments to the development of multiple primary tumours in the context of germline TP53 mutations.Eur J Cancer. 2018 Sep;101:254-262. doi: 10.1016/j.ejca.2018.06.011. Epub 2018 Jul 30. Eur J Cancer. 2018. PMID: 30072235
-
Potential of Advexin: a p53 gene-replacement therapy in Li-Fraumeni syndrome.Future Oncol. 2008 Dec;4(6):759-68. doi: 10.2217/14796694.4.6.759. Future Oncol. 2008. PMID: 19086841 Review.
-
Germline TP53 mutations and Li-Fraumeni syndrome.Hum Mutat. 2003 Mar;21(3):313-20. doi: 10.1002/humu.10185. Hum Mutat. 2003. PMID: 12619118 Review.
Cited by
-
Prediction of chemical-induced acute toxicity using in vitro assay data and chemical structure.Toxicol Appl Pharmacol. 2024 Nov;492:117098. doi: 10.1016/j.taap.2024.117098. Epub 2024 Sep 7. Toxicol Appl Pharmacol. 2024. PMID: 39251042
-
Securidaca-saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells.Cancer Manag Res. 2018 Nov 15;10:5709-5724. doi: 10.2147/CMAR.S163328. eCollection 2018. Cancer Manag Res. 2018. PMID: 30532593 Free PMC article.
-
Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation.FASEB Bioadv. 2020 Sep 2;2(11):653-667. doi: 10.1096/fba.2020-00044. eCollection 2020 Nov. FASEB Bioadv. 2020. PMID: 33205006 Free PMC article.
-
Mechanistic roles of microRNAs in hepatocarcinogenesis: A study of thioacetamide with multiple doses and time-points of rats.Sci Rep. 2017 Jun 8;7(1):3054. doi: 10.1038/s41598-017-02798-7. Sci Rep. 2017. PMID: 28596526 Free PMC article.
-
Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.Hum Mol Genet. 2017 Jul 15;26(14):2591-2602. doi: 10.1093/hmg/ddx106. Hum Mol Genet. 2017. PMID: 28369373 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous